InvestSMART

PYC Therapeutics Limited (ASX: PYC) - Announcements

Current share price for PYC : $2.530 0.06 (2.43%)+

ASX company news and announcements for PYC Therapeutics Limited (PYC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PYC Therapeutics Limited (PYC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PYC Therapeutics Limited (PYC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PYC Therapeutics Limited (PYC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,488 New Patent allowed for Phylogica`s anti-inflammatory peptide 3 Aug 2009 1:19PM $0.059 $2.530 risen by 4,188.14%
$2,488 Appendix 4C - quarterly 29 Jul 2009 4:59PM $0.050 $2.530 risen by 4,960%
$2,488 Pro-forma Cash Position 31 March 2009 5 May 2009 12:47PM $0.078 $2.530 risen by 3,143.59%
$2,488 Appendix 4C - quarterly 30 Apr 2009 12:57PM $0.069 $2.530 risen by 3,566.67%
$2,488 Drug Delivery Collaboration 14 Apr 2009 12:10PM $0.070 $2.530 risen by 3,514.29%
$2,488 Collaboration with the MRC Hutchison Institute a success 4 Mar 2009 6:29PM $0.050 $2.530 risen by 4,960%
$2,488 Half Yearly Report and Accounts 27 Feb 2009 3:21PM $0.045 $2.530 risen by 5,522.22%
$2,488 Capital Raising Programme 26 Feb 2009 6:49PM $0.050 $2.530 risen by 4,960%
$2,488 Appendix 4C - quarterly 30 Jan 2009 11:59AM $0.060 $2.530 risen by 4,116.67%
$2,488 Company Update 22 Dec 2008 8:27AM $0.040 $2.530 risen by 6,225%
$2,488 Company Update 22 Dec 2008 8:27AM $0.040 $2.530 risen by 6,225%
$2,488 Phylogica aquires all shares in associate 24 Nov 2008 12:33PM n/a $2.530 n/a
$2,488 Appendix 4C - quarterly 24 Oct 2008 2:58PM $0.070 $2.530 risen by 3,514.29%
$2,488 Phylogica Signs Cancer Agreement 4 Sep 2008 9:59AM $0.086 $2.530 risen by 2,841.86%
$2,488 Preliminary Final Report 29 Aug 2008 9:09AM $0.090 $2.530 risen by 2,711.11%
$2,488 Appendix 4C - quarterly 30 Jul 2008 3:52PM n/a $2.530 n/a
$2,488 Appendix 4C - quarterly 30 Apr 2008 12:27PM $0.070 $2.530 risen by 3,514.29%
$2,488 Dynamic Licence Annoucement 17 Mar 2008 12:32PM $0.100 $2.530 risen by 2,430%
$2,488 Appendix 4D 28 Feb 2008 12:53PM $0.100 $2.530 risen by 2,430%
$2,488 Extra Funding for Phylogica Programme 19 Feb 2008 10:55AM $0.135 $2.530 risen by 1,774.07%
$2,488 Appendix 4C - quarterly 31 Jan 2008 12:18PM n/a $2.530 n/a
$2,488 Co-Marketing Agreement 21 Jan 2008 11:44AM $0.140 $2.530 risen by 1,707.14%
$2,488 Strategic Direction Announcement 6 Dec 2007 9:59AM $0.225 $2.530 risen by 1,024.44%
$2,488 Appendix 4C - quarterly 30 Oct 2007 9:27AM $0.220 $2.530 risen by 1,050%
$2,488 Burns Drug for Human Trials 23 Oct 2007 12:27PM $0.240 $2.530 risen by 954.17%

876 - 900 of 947 results

Page 36 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.